Listen to Medscape InDiscussion: Bipolar Disorder, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/999796). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Medscape InDiscussion: Bipolar Disorder
Claim This Podcastby Medscape
5.0(3 reviews)
6 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Listen to Medscape InDiscussion: Bipolar Disorder, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/999796). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Language
🇺🇲
Publishing Since
3/27/2024
1 verified contact email on file for Medscape InDiscussion: Bipolar Disorder
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 30, 2024
The Future of Bipolar Disorder Treatment With Psychedelics and Neuromodulation
<p>Drs Trisha Suppes and Scott T. Aaronson discuss rapid-acting therapies for bipolar disorder and the future of psychedelics and neuromodulation in its treatment.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999802. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p><strong>Resources</strong></p> <p>Bipolar Disorder https://emedicine.medscape.com/article/286342-overview</p> <p>The Effects of Vagus Nerve Stimulation on the Course and Outcomes of Patients With Bipolar Disorder in a Treatment-Resistant Depressive Episode: A 5-Year Prospective Registry https://pubmed.ncbi.nlm.nih.gov/32358769/</p> <p>A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality https://pubmed.ncbi.nlm.nih.gov/28359201/</p> <p>c-Fos and pERK, Which Is a Better Marker for Neuronal Activation and Central Sensitization After Noxious Stimulation and Tissue Injury? https://pubmed.ncbi.nlm.nih.gov/19898681/</p> <p>Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Disorder https://pubmed.ncbi.nlm.nih.gov/33282175/</p> <p>Efficacy of Active vs Sham Intermittent Theta Burst Transcranial Magnetic Stimulation for Patients With Bipolar Depression: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/33710288/</p> <p>A Retrospective Analysis of Bipolar Depression Treated With Transcranial Magnetic Stimulation https://pubmed.ncbi.nlm.nih.gov/33169946/</p> <p>When to Hold and When to Fold: Early Prediction of Nonresponse to Transcranial Magnetic Stimulation in Major Depressive Disorder https://pubmed.ncbi.nlm.nih.gov/38458381/</p> <p>Dosing Transcranial Magnetic Stimulation in Major Depressive Disorder: Relations Between Number of Treatment Sessions and Effectiveness in a Large Patient Registry https://pubmed.ncbi.nlm.nih.gov/37827360/</p> <p>Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and Design https://pubmed.ncbi.nlm.nih.gov/15061154/</p> <p>Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Controlled Trial https://pubmed.ncbi.nlm.nih.gov/38055270/</p>
June 27, 2024
Managing the Interplay of Bipolar Disorder and Substance Use Disorders
<p>Drs Trisha Suppes and Michael J. Ostacher discuss treatments for patients with bipolar disorder who also have substance abuse disorder.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999801. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p><strong>Resources</strong></p> <p>Bipolar Disorder https://emedicine.medscape.com/article/286342-overview</p> <p>Management of Comorbid Bipolar Disorder and Substance Use Disorders https://pubmed.ncbi.nlm.nih.gov/28301219/</p>
May 30, 2024
The Importance of Managing Circadian Rhythms in Patients With Bipolar Disorder
<p>Drs Trisha Suppes and Holly A. Swartz discuss the impact of circadian and social rhythms on patients with bipolar disorder, as well as the power of psychotherapy.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999800. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p><strong>Resources</strong></p> <p>Bipolar Disorder https://emedicine.medscape.com/article/286342-overview</p> <p>Circadian Rhythm in Bipolar Disorder: A Review of the Literature https://pubmed.ncbi.nlm.nih.gov/29869403/</p> <p>Efficacy of the Interpersonal and Social Rhythm Therapy (IPSRT) in Patients With Bipolar Disorder: Results From a Real-World, Controlled Trial https://pubmed.ncbi.nlm.nih.gov/32165907/</p> <p>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 Guidelines for the Management of Patients With Bipolar Disorder https://pubmed.ncbi.nlm.nih.gov/29536616/</p> <p>Psychotherapy Alone and Combined With Medication as Treatments for Bipolar II Depression: A Randomized Controlled Trial https://pubmed.ncbi.nlm.nih.gov/28703949/</p> <p>26th Annual Conference of the International Society for Bipolar Disorders September 29 – October 1, 2024 Reykjavik, Iceland https://www.isbd.org/Program</p> <p>Nutrition and Bipolar Disorder: A Systematic Review https://pubmed.ncbi.nlm.nih.gov/35608150/</p> <p>Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Controlled Trial https://pubmed.ncbi.nlm.nih.gov/38055270/</p> <p>Brain Stimulation Treatment for Bipolar Disorder https://pubmed.ncbi.nlm.nih.gov/36515461/</p>
6 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Medscape InDiscussion: Bipolar Disorder
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Medscape InDiscussion: Bipolar Disorder?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.